Comprehensive Score for financial Toxicity - FACIT-COST
COST is a 12-item FACIT measure of financial toxicity over the past 7 days, with an 11-item total and one unscored summary item. This page is catalogue information. Lower totals indicate greater financial toxicity for clinician review, not a diagnosis.
Overview
What is the COST?
The Comprehensive Score for financial Toxicity asks about money strain linked to illness and treatment. Lower totals indicate greater financial toxicity. Published grades run from Grade 0 (26 or more) to Grade 3 (0) for clinician consideration. They do not determine benefits, billing, or treatment choice.
Development and clinical use
de Souza and colleagues developed COST with FACIT. Lirena presents COST - FACIT Version 2, which adds the unscored FT12 summary item to the 11 scored items.
- Catalogue status
- Catalogue information
- Mode
- Patient self-report
- Typical use
- Review financial strain related to treatment
- Direction
- Lower totals indicate greater toxicity
- Source
- FACIT
- Clinical role
- Screening support
Administration
A focused client experience
COST is completed as a focused self-report and stored for clinician review. This public page does not collect answers or return a score.
- One question at a time with visible progress
- Large keyboard-operable response choices
- Previous, next, and answer-review steps
- Clear confirmation that results go to the clinic
The illustration shows layout only. It does not reproduce COST item wording.
Report showcase
Designed to make evidence easy to review
The downloadable synthetic example illustrates report layout using invented response patterns, without patient data or instrument questions.
- Named instrument, version, and provenance
- Item-level response pattern without source wording
- Methodology, references, and clinical boundary
- Responsible clinician review rather than automated conclusions
Clinician review required
Methodology
Understand the measure and its scoring conventions
Published scoring conventions may exist in official materials. This public page does not independently verify scoring, cutoffs, or a production scoring rule. Use the official form and scoring instructions for the version you intend to use.
References
- FACIT COST measureFACIT. Comprehensive Score for financial Toxicity (COST).
- COST validationde Souza JA, Yap BJ, Wroblewski K, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017;123(3):476-484.
Questions
What clinics ask before they evaluate the COST
These answers stay inside educational catalogue scope. They do not replace official manuals or clinician judgement.
Does a low COST total diagnose financial hardship as a disorder?
No. Lower totals indicate greater financial toxicity for clinician review. They are not a diagnosis.
Can I complete COST here?
No. This landing does not collect answers or return a score.
Does COST decide treatment affordability?
No. It records reported financial strain. Billing, benefits, and treatment decisions remain with the clinic and the person.
Is this a credit or means test?
No. It is a patient-reported measure for clinician review.
See who needs psychosocial attention, why, and whether they are improving.
More Oncology assessments
PROMIS Short Form v1.0 - Fatigue 4a
Catalogue information on the measure's purpose, source and administration requirements.
Distress ThermometerNCCN Distress Thermometer
Catalogue information on the measure's purpose, source and administration requirements.
DT Problem ListNCCN Distress Thermometer Problem List
Catalogue information on the measure's purpose, source and administration requirements.